Hae‐Ock Lee

Catholic University of Korea — South Korea

Biochemistry, Genetics and Molecular Biology · Life Sciences

26h-index5.8kcitations123works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(41), Multiple Myeloma Research and Treatments(26), Cancer Immunotherapy and Biomarkers(21), Single-cell and spatial transcriptomics(21), Immune cells in cancer(16)

Publications123 total

Single-nucleus multi-omics delineates distinct epigenetic programs associated with tumor progression in lung adenocarcinoma
Clinical Epigenetics·2026Open Access
Selective inhibition of long isoforms of phosphodiesterase 4D mitigates liver fibrosis in mouse models
Journal of Clinical Investigation·2025· 2 citedOpen Access
Author response: Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer
2024Open Access
Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer
eLife·2024· 5 citedOpen Access
Author response: Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer
2024Open Access
Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer
2024Open Access
Single-cell RNA sequencing of nc886, a non-coding RNA transcribed by RNA polymerase III, with a primer spike-in strategy
PLoS ONE·2024Open Access
Single-cell RNA sequencing revealed the role of the Th17 pathway in the development of anti- human leukocyte antigen antibodies in a highly sensitized mouse model
Kidney Research and Clinical Practice·2024· 2 citedOpen Access
Reviewer #2 (Public Review): Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer
2024Open Access
Reviewer #1 (Public Review): Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer
2024Open Access
Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer
eLife·2024Open Access
Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer
2024Open Access
Author response: Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer
2024Open Access
Characterization of an orthotopic mouse transplant model reveals early changes in the tumor microenvironment of lung cancer
BMB Reports·2024· 1 citedOpen Access
Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer
2024· 1 citedOpen Access
Single cell RNA sequencing of nc886, a non-coding RNA transcribed by RNA polymerase III, with a primer spike-in strategy
2024Open Access
Single-cell RNA sequencing reveals myeloid and T cell co-stimulation mediated by IL-7 anti-cancer immunotherapy
British Journal of Cancer·2024· 17 citedOpen Access
Altered tumor signature and T‐cell profile after chemotherapy reveal new therapeutic opportunities in high‐grade serous ovarian carcinoma
Cancer Science·2024· 7 citedOpen Access
Comprehensive profiling of DNA methylation in Korean patients with colorectal cancer
BMB Reports·2024· 1 citedOpen Access
Supplementary Table 4 from Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary Progression Affect Proliferation and Immune Evasion
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Woong‐Yang Park(28), Nayoung Kim(16), Hye Hyeon Eum(16), Areum Jo(13), Je‐Gun Joung(9), Hyun‐Sook Lee(8), Yourae Hong(7), Woosung Chung(7), Daeun Ryu(5), Seok Jin Kim(5), Kihyun Kım(5), Huiram Kang(5), Jung Kyoon Choi(4), Eunhee Choi(4), Dasom Jeong(4), Hong Kwan Kim(3), Jung-Il Lee(3), Myung‐Ju Ahn(3), Kyu‐Tae Kim(3), Kyeung Min Joo(3)